Your browser doesn't support javascript.
loading
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study.
Nolan, Claire M; Polgar, Oliver; Schofield, Susie J; Patel, Suhani; Barker, Ruth E; Walsh, Jessica A; Ingram, Karen A; George, Peter M; Molyneaux, Philip L; Maher, Toby M; Man, William D-C.
Afiliación
  • Nolan CM; Harefield Respiratory Research Group, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England; National Heart and Lung Institute, Imperial College London, London, England; Brunel University London, College of Health Medicine and Life Sciences, London,
  • Polgar O; Harefield Respiratory Research Group, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England.
  • Schofield SJ; National Heart and Lung Institute, Imperial College London, London, England.
  • Patel S; Harefield Respiratory Research Group, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England; National Heart and Lung Institute, Imperial College London, London, England.
  • Barker RE; Harefield Respiratory Research Group, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England; National Heart and Lung Institute, Imperial College London, London, England; Wessex Academic Health Science Network, Southampton, England.
  • Walsh JA; Harefield Respiratory Research Group, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England.
  • Ingram KA; Harefield Pulmonary Rehabilitation Unit, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England.
  • George PM; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England; National Heart and Lung Institute, Imperial College London, London, England.
  • Molyneaux PL; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England; National Heart and Lung Institute, Imperial College London, London, England.
  • Maher TM; Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England; National Heart and Lung Institute, Imperial College London, London, England; Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Man WD; Harefield Respiratory Research Group, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England; Harefield Pulmonary Rehabilitation Unit, Royal Brompton and Harefield Clinical Group, Guy's and St. Thomas' NHS Foundation Trust, London, England; National
Chest ; 161(3): 728-737, 2022 03.
Article en En | MEDLINE | ID: mdl-34699771
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Fibrosis Pulmonar Idiopática Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Chest Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Fibrosis Pulmonar Idiopática Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Chest Año: 2022 Tipo del documento: Article